HomeCompareDTXMF vs QYLD

DTXMF vs QYLD: Dividend Comparison 2026

DTXMF yields 2099.96% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTXMF wins by $15665483173.77M in total portfolio value
10 years
DTXMF
DTXMF
● Live price
2099.96%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15665483173.80M
Annual income
$14,323,699,878,768,094.00
Full DTXMF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — DTXMF vs QYLD

📍 DTXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTXMFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTXMF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTXMF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTXMF
Annual income on $10K today (after 15% tax)
$178,496.43/yr
After 10yr DRIP, annual income (after tax)
$12,175,144,896,952,880.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, DTXMF beats the other by $12,175,144,896,948,070.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTXMF + QYLD for your $10,000?

DTXMF: 50%QYLD: 50%
100% QYLD50/50100% DTXMF
Portfolio after 10yr
$7832741586.91M
Annual income
$7,161,849,939,386,877.00/yr
Blended yield
91.43%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTXMF buys
0
QYLD buys
0
No recent congressional trades found for DTXMF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTXMFQYLD
Forward yield2099.96%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$15665483173.80M$25.4K
Annual income after 10y$14,323,699,878,768,094.00$5,659.31
Total dividends collected$15570599104.15M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: DTXMF vs QYLD ($10,000, DRIP)

YearDTXMF PortfolioDTXMF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$220,696$209,995.80$10,352$1,192.36+$210.3KDTXMF
2$4,567,471$4,331,326.27$10,830$1,347.57+$4.56MDTXMF
3$88,663,041$83,775,847.71$11,460$1,539.07+$88.65MDTXMF
4$1,614,723,560$1,519,854,105.24$12,275$1,777.84+$1614.71MDTXMF
5$27,596,399,156$25,868,644,947.25$13,323$2,078.95+$27596.39MDTXMF
6$442,712,758,641$413,184,611,544.43$14,667$2,463.34+$442712.74MDTXMF
7$6,668,541,041,184$6,194,838,389,437.68$16,396$2,960.57+$6668541.02MDTXMF
8$94,343,071,214,447$87,207,732,300,379.95$18,631$3,612.97+$94343071.20MDTXMF
9$1,254,003,079,467,744$1,153,055,993,268,286.20$21,548$4,482.15+$1254003079.45MDTXMF
10$15,665,483,173,798,580$14,323,699,878,768,094.00$25,398$5,659.31+$15665483173.77MDTXMF

DTXMF vs QYLD: Complete Analysis 2026

DTXMFStock

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers esophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Full DTXMF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this DTXMF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTXMF vs SCHDDTXMF vs JEPIDTXMF vs ODTXMF vs KODTXMF vs MAINDTXMF vs XYLDDTXMF vs JEPQDTXMF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.